Neurological Manifestations in Children Diagnosed With Inflammatory Bowel Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorBishoy Shehata Fahim

About this trial

screen for neurologic and psychiatric disorders in children and

adolescents with IBD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients with IBD aged from from 1 to18 years old.

Disqualifiers

patients with IBD and aged above 18 years old or below 1 year old

Trial population

Children diagnosed with inflammatory bowel disease in Assiut university child hospital

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Screening for Neurological manifestations among children diagnosed with inflammatory bowel disease in Assiut university children hospital

Neurologic symptoms have a great importance in early diagnosis and treatment preventing major morbidity and later sequelae, especially if they precede GI symptoms The prevalence of neurologic manifestations of IBD varies between 0.2% and 36%. Their pathogenesis of neurologic manifestations in IBD consists of 6 mechanisms: 1.malabsorption and nutritional deficiency 2.metabolic agents 3.infections complicating immune suppression 4.side effects of medications or iatrogenic as a surgical complication 5.thromboembolism 6.immunological factors UC patients are similar to or higher than CD patients in the probability of neurologic symptoms. Neurologic manifestations and complications include: headache, dizziness, hypotonia, ADHD, tics, sensory complaints, seizures, neuropsychiatric disorders, peripherial neuropathy, meningitis, vestibular dysfunction, idiopathic IC hypertension, cerebral vasculitis, demyelinating disorders and migraine

Time frame
during the period from January 2026 to January 2027.
2

screen for neurologic and psychiatric disorders in children and adolescents with IBD.

Time frame
1 year

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bishoy Shehata Fahim

Lead sponsor

Assiut University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: